Evozym Biologics Inc - DE Sussex, Lewes 19958

Evozym Biologics Inc entered the industry of Commercial Biotechnical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Joseph Grzymski by calling (302) 249-5458 during business hours. You can also write to the business’ Single Location at 19812 Shirling Lane, Lewes, Delaware DE 19958. You can also visit the company’s website at evozym.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Evozym Biologics Inc
Representative: Joseph Grzymski
Place of Business: 19812 Shirling Lane, Lewes, DE 19958
Contact Number: (302) 249-5458
Website: evozym.com
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Evozym Biologics Inc is a company operating from Sussex, Delaware providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Evozym Biologics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Joseph Grzymski at (302) 249-5458 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 19812 Shirling Lane in Lewes, Delaware 19958 and can be engaged online through the company website at evozym.com, the company Twitter , and Facebook page .